Volume 56, Issue 6, Pages (December 2009)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 4, Pages (October 2012)
Advertisements

Early Detection of Prostate Cancer in 2007
Volume 55, Issue 1, Pages 1-8 (January 2009)
The PSA Era is not Over for Prostate Cancer
Volume 71, Issue 6, Pages (June 2017)
Volume 64, Issue 6, Pages (December 2013)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 6, Pages (December 2003)
Volume 70, Issue 5, Pages (November 2016)
Testosterone Therapy in Men With Prostate Cancer
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 53, Issue 4, Pages (April 2008)
Volume 70, Issue 6, Pages (December 2016)
Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging:
Volume 63, Issue 1, Pages (January 2013)
Volume 67, Issue 3, Pages (March 2015)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 6, Pages (December 2013)
Volume 61, Issue 2, Pages (February 2012)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Volume 65, Issue 6, Pages (June 2014)
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
Volume 66, Issue 1, Pages (July 2014)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
Prostate MRI: The Hemorrhage Exclusion Sign
Volume 133, Issue 2, Pages (May 2014)
Prostate Cancer Detection: A View of the Future
Volume 68, Issue 3, Pages (September 2015)
Volume 56, Issue 2, Pages (August 2009)
Volume 66, Issue 3, Pages (September 2014)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 59, Issue 4, Pages (April 2011)
Volume 69, Issue 6, Pages (June 2016)
Counselling the Prostate Cancer Patient
Volume 66, Issue 6, Pages (December 2014)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 72, Issue 5, Pages (November 2017)
Volume 53, Issue 2, Pages (February 2008)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 53, Issue 4, Pages (April 2008)
Volume 66, Issue 2, Pages (August 2014)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 6, Pages (December 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 62, Issue 6, Pages (December 2012)
Volume 48, Issue 6, Pages (December 2005)
Volume 65, Issue 1, Pages (January 2014)
Volume 50, Issue 5, Pages (November 2006)
Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 72, Issue 4, Pages (October 2017)
Testicular Cancer Variations in Time and Space in Europe
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 75, Issue 4, Pages (April 2019)
European Urology is “Your” Journal
Nandita M. deSouza, Veronica A. Morgan, Elizabeth Bancroft, S
Volume 69, Issue 1, Pages (January 2016)
Volume 52, Issue 6, Pages (December 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 56, Issue 6, Pages 981-988 (December 2009) A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance  Nicholas J. van As, Nandita M. de Souza, Sophie F. Riches, Veronica A. Morgan, Sayid A. Sohaib, David P. Dearnaley, Chris C. Parker  European Urology  Volume 56, Issue 6, Pages 981-988 (December 2009) DOI: 10.1016/j.eururo.2008.11.051 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 (A) T2-weighted image and (B) apparent diffusion coefficient (ADC) map in a patient who progressed, showing low signal intensity tumour on T2-W with marked diffusion restriction on the ADC map (arrows). ADC=628mm2/s. European Urology 2009 56, 981-988DOI: (10.1016/j.eururo.2008.11.051) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 2 Receiver operating curve for apparent diffusion coefficient predicting adverse repeat biopsy. European Urology 2009 56, 981-988DOI: (10.1016/j.eururo.2008.11.051) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 3 Receiver operating curve for apparent diffusion coefficient predicting deferred radical treatment. European Urology 2009 56, 981-988DOI: (10.1016/j.eururo.2008.11.051) Copyright © 2008 European Association of Urology Terms and Conditions